Immunoreactivity of p53, Ki-67, and c-erbB-2 in Phyllodes tumors of the breast in correlation with clinical and morphologic features

Journal of Surgical Oncology

Volumn 79, Issue 2, 2002, Pages 86-92

  Shpitz, Baruch ^a   Bomstein, Y ^a   Sternberg, A ^a   Klein, E ^a   Tiomkin, V ^a   Kaufman, A ^a   Groisman, G ^a   Bernheim, J ^a  

^a MEIR MEDICAL CENTER   (Israel)

Author keywords

Breast; C erbB 2; Immunoreactivity; P53; Phyllodes tumor; Proliferation

Indexed keywords

BIOLOGICAL MARKER; GENE PRODUCT; KI 67 ANTIGEN; ONCOPROTEIN; PROTEIN P53;

ADOLESCENT; ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER GROWTH; CANCER RECURRENCE; CELL ACTIVITY; CELL PROLIFERATION; CLINICAL ARTICLE; CYSTOSARCOMA PHYLLOIDES; DISEASE ASSOCIATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; MORPHOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STROMA CELL;

ADOLESCENT; ADULT; AGED; BREAST NEOPLASMS; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MASTECTOMY; MASTECTOMY, SEGMENTAL; MIDDLE AGED; PHENOTYPE; PHYLLODES TUMOR; PROGNOSIS; PROSPECTIVE STUDIES; RECEPTOR, ERBB-2; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0036157396     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/jso.10049     Document Type: Article

References (27)

1. Biphasic tumors
2. The treatment and prognosis of patients with phyllodes tumors of the breast
3. P53 expression in phyllodes tumours is associated with histological features of malignancy but does not predict outcome
4. Sarcomatoid tumours of the breast in Denmark from 1977 to 1978. A clinicopathological and immunohistochemical study of 100 cases
5. Surgical treatment of phyllodes tumors of the breast
6. Fibroepithelial neoplasms
7. The clinical and histological criteria that predict metastases from cystosarcoma phyllodes
8. Cystosarcoma phyllodes: A clinicopathological analysis of 42 cases
9. DNA content and proliferative activity of cystosarcoma phyllodes of the breast. Potential prognostic significance
10. Phyllodes tumour of the breast: Immunohistochemical study of 37 tumour using MIB1 antibody
11. PT of the breast analyzed by comparative genomic hybridization and association of increased 1q copy number with stromal overgrowth and recurrence
12. Altered expression of p53 and its regulated proteins in phyllodes tumours of the breast
13. Malignant pyllodes tumours of the breast display increased stromal p53 protein expression
14. Cystosarcoma phyllodes of the breast prognostic significance of proliferation and apoptosis related genes
15. Cystosarcoma phyllodes. A clinicopathological study of 26 cases
16. Immunohistochemical study of MIB1 expression in phyllodes tumors and fibroadenoma
17. Molecular analysis of phyllodes tumors reveals distinct changes in the epithelial and stromal components
18. Treatment options and recurrence potential for cystosarcoma phyllodes
19. Histologic features predict local recurrence after breast conserving therapy of phyllodes tumors
20. Phyllodes tumors of the breast: A review of 32 cases
21. Factors leading to local recurrence or death after surgical resection of phyllodes tumours of the breast
22. Surgical management of phyllodes tumors
23. Cystosarcoma phyllodes: A review of surgical options
24. Which therapy for unexpected phyllode tumour of the breast?
25. Phyllodes tumor: Clinicopathological review of 60 patients and flow cytometric analysis in 30 patients
26. Phyllodes tumours of the breast: A clinicopathological review of thirty-two cases
27. Biological continuum of benign, atypical and malignant mesenchymal neoplasms-does it exist?